TCBPW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW
Should you be buying TC Biopharm stock or one of its competitors? The main competitors of TC Biopharm include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.
180 Life Sciences (NASDAQ:ATNFW) and TC Biopharm (NASDAQ:TCBPW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings, community ranking and dividends.
In the previous week, TC Biopharm's average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.
180 Life Sciences and TC Biopharm both received 0 outperform votes by MarketBeat users.
Summary
180 Life Sciences and TC Biopharm tied by winning 1 of the 2 factors compared between the two stocks.
Get TC Biopharm News Delivered to You Automatically
Sign up to receive the latest news and ratings for TCBPW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TCBPW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TCBPW vs. The Competition
TC Biopharm Competitors List
Related Companies and Tools
